Growth Metrics

Acadia Pharmaceuticals (ACAD) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Acadia Pharmaceuticals (ACAD) over the last 9 years, with Q3 2025 value amounting to $111.6 million.

  • Acadia Pharmaceuticals' Goodwill & Intangibles rose 578.12% to $111.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.6 million, marking a year-over-year increase of 578.12%. This contributed to the annual value of $119.8 million for FY2024, which is 8290.12% up from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Goodwill & Intangibles of $111.6 million as of Q3 2025, which was up 578.12% from $114.3 million recorded in Q2 2025.
  • Acadia Pharmaceuticals' Goodwill & Intangibles' 5-year high stood at $119.8 million during Q4 2024, with a 5-year trough of $369000.0 in Q2 2021.
  • Its 4-year average for Goodwill & Intangibles is $81.4 million, with a median of $105.5 million in 2024.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first plummeted by 8001.08% in 2021, then soared by 8290.12% in 2024.
  • Over the past 4 years, Acadia Pharmaceuticals' Goodwill & Intangibles (Quarter) stood at $369000.0 in 2021, then skyrocketed by 17647.97% to $65.5 million in 2023, then soared by 82.9% to $119.8 million in 2024, then dropped by 6.82% to $111.6 million in 2025.
  • Its Goodwill & Intangibles stands at $111.6 million for Q3 2025, versus $114.3 million for Q2 2025 and $117.1 million for Q1 2025.